Almost 2000 people with leukaemia, advanced kidney cancer, bladder cancer and liver cancer will have affordable access to new treatment options, paying as little as AU$6.50 a script.
Over 5000 patient data will be used to identify image changes and patterns in liver cancer, helping physicians make better treatment decisions
Johnson & Johnson Vision study reveals 7 in 10 Singaporeans and 8 in 10 Thais suffer from symptoms of Meibomian Gland Dysfunction but do not seek professional help, putting eyesight at risk
Indee Labs microfluidic vortex shedding potential alternative to current gene-modified cell therapy manufacturing
It is also the first AstraZeneca medicine ever approved for type-1 diabetes